As slow as the rollout of COVID-19 vaccines has been in the United States, some estimates say billions of people around the world won't be vaccinated for COVID-19 until 2022 or 2023.
Bloomberg has been publishing a map that shows the level of vaccine distribution in different countries and virtually the entire continent of Africa — more than 50 nations — is blank.
"In Africa, we don't have the resources. It's as simple as that," Sirleaf says "Unless vaccine is seen as a free good on the basis that until everyone is safe, no one is safe — when it's seen in that context, then perhaps the wealthier nations of the world will come up with a formula that says, how can we share the vaccine with those countries that are under resourced?"
Read the full article.
Refana Inc., is United States registered private corporation dedicated to finding practical and innovative solutions to the world's medical problems. By utilizing a highly collaborative open source system of research and development Refana has been able to attract world leaders in their respective scientific and medical fields to work on these problems. Through this model Refana hopes to greatly accelerate the vaccine development process for Covid-19 and help protect not only the health of the world, but also the economies and stability of nations at risk.